Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.
Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.
